Sai Life Sciences Sets New Standards in Sustainability
Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), a pioneering Contract Research, Development, and Manufacturing Organization (CRDMO), has recently reached a significant milestone by having its near-term targets to reduce greenhouse gas (GHG) emissions validated by the Science Based Targets initiative (SBTi). This organization is instrumental in engaging corporations and financial institutions globally to tackle the climate crisis.
Understanding SBTi Validation
The validation from SBTi is not merely an organizational certification; it is a confirmation of Sai Life Sciences's serious commitment towards sustainability in the pharmaceutical sector. As explained by Krishna Kanumuri, the CEO & Managing Director of Sai Life Sciences, the company's extensive role in the pharmaceutical value chain—ranging from research to manufacturing—makes it crucial to adopt sustainability practices effectively. The validation reflects the commitment to embedding low-carbon innovation in every aspect of their operations, facilitating the delivery of life-changing medicines without compromising the environment.
Targets Set for GHG Emission Reduction
Sai Life Sciences joined the SBTi in June 2023, pledging to set comprehensive near-term GHG reduction targets. Specifically, the organization aims to achieve a remarkable 58.8% reduction in absolute scope 1 and scope 2 GHG emissions by FY2035, using FY2024 as a baseline. Additionally, they are committed to a 63.8% reduction in scope 3 GHG emissions related to purchased goods, capital goods, energy activities, transportation, and employee commuting, all aligned to enhance their sustainability efforts over the same timeframe.
Advancements in Sustainability Initiatives
In alignment with its commitments, Sai Life Sciences has made remarkable strides in its sustainability agenda. A few key highlights of their ongoing efforts include:
Renewable Energy Goals
In 2023, Sai Life Sciences unveiled a revamped set of Sustainable Development Goals (SDGs) aimed at achieving specific environmental, social, and governance (ESG) benchmarks by the end of the fiscal year March 31, 2027. The company aims to reduce GHG emissions by 30% and achieve 70% of its energy needs from renewable sources.
Reduction in Coal Usage
During FY25, Sai Life Sciences increased its reliance on renewable energy significantly, achieving 96% in Bidar, thereby preventing the emission of 16,038 MT of CO?. Presently, renewables account for 54% of their total energy consumption, with ambitions to reach 70% by FY27 and 80% by FY30.
Partnerships for a Greener Future
The organization has also partnered with DHL GoGreen to reduce logistics-related emissions by a significant 90%. This collaboration aims to streamline logistics processes while also addressing environmental concerns.
Pioneering Memberships
Sai Life Sciences is proud to be the first company in India to join the Pharmaceutical Supply Chain Initiative (PSCI), indicating an industry-leading commitment to responsible supply chain practices.
Conclusion: A Future-Oriented Approach to Sustainability
With the validation from SBTi, transparent SDG objectives, and consistent dedication to advancing its sustainability agenda, Sai Life Sciences is on a commendable path to make a long-lasting impact on the environment and the pharmaceutical sector as a whole. Their initiatives are not just corporate responsibilities—they are a fuller commitment to fostering a sustainable future for generations to come.
Frequently Asked Questions
What is Sai Life Sciences's recent achievement related to climate action?
Sai Life Sciences has secured validation from the Science Based Targets initiative for its near-term greenhouse gas emissions reduction targets.
What are the greenhouse gas reduction targets set by Sai Life Sciences?
The company aims to reduce absolute scope 1 and scope 2 GHG emissions by 58.8% by FY2035 and scope 3 emissions by 63.8% in the same period.
How is Sai Life Sciences promoting renewable energy?
They have achieved 96% reliance on renewable energy in specific locations and plan to increase this to 70% by FY27 and 80% by FY30.
What partnerships has Sai Life Sciences formed to support sustainability?
Sai Life Sciences has partnered with DHL GoGreen to reduce logistics-related emissions by 90% as part of its sustainability initiatives.
What industry recognition has Sai Life Sciences achieved for its sustainability efforts?
Sai Life Sciences is the first India-based company to join the Pharmaceutical Supply Chain Initiative, showcasing its leadership in responsible practices.
